首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1355807

皮膚科-皮膚護理及美容自我護理市場現況及未來趨勢

Dermatologicals - Exploring the Current & Future Self-Care Market for Skin Care and Aesthetics

出版日期: 2024年02月29日 | 出版商:

Nicholas Hall Group of Companies | 英文 442 Pages | 訂單完成後即時交付

價格

簡介目錄

疫情使衛生和個人照護成為世界各地消費者前所未有的關注點。雖然防腐劑和消毒劑在疫情後的企穩在一定程度上減緩了整體銷量，但許多市場動態仍然強勁，創造了一個充滿活力和未來成長機會的市場。對唇部護理、痤瘡治療和傷口護理產品的強勁需求只是強勁需求的幾個跡象。電商保養品市場銷售額近30億美元，並且正在經歷強勁的年成長。

發布活動仍然是推動成長的關鍵，交付形式和配方的創新頻繁發生，而手術後恢復等利基領域正在尋找新的受眾。您也許能夠獲得它。事實證明，A+P 投資是多個領域的重要動力。行銷人員正在轉向數位管道來教育消費者並推廣他們的產品。個人化也是一個關鍵趨勢，消費者尋求的不僅僅是 "一刀切" 的護膚解決方案。

本報告對八個主要國家（及其他主要市場）的皮膚科市場進行了深入研究，內容涵蓋主要國家的法規和分類、各種皮膚病藥物的趨勢、主要品牌的表現和上市活動。正在分析中。

摘要
分佈
法規與分類
抗真菌藥物
傷口癒合藥
防腐劑和消毒劑
止癢
治療痤瘡的藥物
女性私人護理
唇部護理
痔瘡處方藥
循環輔助設備
掉髮治療
濕疹與牛皮癬
頭皮護理
治療唇皰疹
蝨子治療
疣和疣的治療
頭髮和美容補充劑
展望、預測、機遇

德國

摘要
分佈
法規與分類
抗真菌藥物
傷口癒合藥
防腐劑和消毒劑
止癢
治療痤瘡的藥物
女性私人護理
唇部護理
痔瘡處方藥
循環輔助設備
掉髮治療
濕疹與牛皮癬
頭皮護理
治療唇皰疹
蝨子治療
疣、疣的治療
頭髮和美容補充劑
展望、預測、機遇

義大利

摘要
分佈
法規與分類
抗真菌藥物
傷口癒合藥
防腐劑和消毒劑
止癢
治療痤瘡的藥物
女性私人護理
唇部護理
痔瘡處方藥
循環輔助設備
掉髮治療
濕疹與牛皮癬
頭皮護理
治療唇皰疹
蝨子治療
疣和疣的治療
頭髮和美容補充劑
展望、預測、機遇

日本

摘要
分佈
法規與分類
抗真菌藥物
防腐劑和消毒劑
止癢
治療痤瘡的藥物
唇部護理
痔瘡處方藥
掉髮治療
濕疹與牛皮癬
頭皮護理
疣和疣的治療
頭髮和美容補充劑
展望、預測、機遇

英國

摘要
分佈
法規與分類
抗真菌藥物
傷口癒合藥
防腐劑和消毒劑
止癢
治療痤瘡的藥物
女性私人護理
唇部護理
痔瘡處方藥
掉髮治療
濕疹與牛皮癬
頭皮護理
治療唇皰疹
蝨子治療
疣和疣的治療
頭髮和美容補充劑
展望、預測、機遇

美國

摘要
分佈
法規與分類
抗真菌藥物
傷口癒合藥
防腐劑和消毒劑
止癢
治療痤瘡的藥物
女性私人護理
唇部護理
痔瘡處方藥
掉髮治療
濕疹與牛皮癬
頭皮護理
治療唇皰疹
蝨子治療
疣和疣的治療
頭髮和美容補充劑
展望、預測、機遇

選定市場概覽

澳大利亞
加拿大
印度
墨西哥
波蘭
韓國

品牌案例研究

CeraVe
Cetaphil
ChapStick
Mighty Patch

展望

世界短期展望
對世界的長期展望
主要市場的短期前景
主要市場的長期前景

簡介目錄

There are countless opportunities for marketers to capitalise on the growth potential of skincare and aesthetic products, and the pandemic has shown that hygiene and personal care have become unprecedented concerns for consumers across the world.

With overall sales held back to a degree by the stabilisation of antiseptics & disinfectants following a pandemic-related spike, much of the Derma market is actually in rude health, featuring exciting pockets of dynamism and opportunities for future growth. Strong showings among lip care, acne remedies and wound healers are just a few signs of strong demand. The picture is even brighter online, with the e-commerce skincare market taking almost $3bn in sales and enjoying year-on-year strong growth.

Launch activity remains key to driving growth, with innovations in delivery format and formula frequent, while niches such as post-surgery recovery can potentially reach new audiences. A+P investment has proved an important growth driver in some areas - with marketers turning to digital channels to educate consumers and promote their products. Personalisation is also a key trend, with consumers looking for something more than a "one-size-fits-all" skincare solution.

By examining 8 core markets in detail (and additional key markets in brief), analysing brand performances and launch activity, our latest Dermatologicals report aims to investigate the untapped potential in this CHC category.

Key Features of the report:

An in-depth exploration of the Dermatologicals market, including Antifungals, Wound healers, Acne remedies, Anti-itch & more, plus coverage of adjacencies such as Hair & beauty supplements
Coverage of 8 major countries from across the globe, with topline sales, brand performances, new developments, launches and promotional campaigns, as well as additional key markets in brief
Very latest mid-year 2023 sales from DB6 , our dedicated CHC sales database, plus historical growth rates to help track performance fluctuations
Antifungals sales segmented into general, VYI and nail presentations
Case studies of key Derma brands, highlighting success factors, sales, NPD and A+P activity, including digitally-native and online brands
A look to the future includes long-term forecast sales for all categories and countries to 2027 & 2032, plus the most up-to-date short-term forecasts

Circulatory aids
Hair loss treatments
Eczema & psoriasis
Scalp treatments
Cold sore treatments
Lice treatments
Wart & verruca treatments
Hair & beauty supplements^*

^*sales tracked under VMS in DB6.

8 individual markets profiled in depth:

Italy
Germany
France
China

USA
UK
Japan
Brazil

Plus selected additional markets in brief:

S Korea
Poland
Mexico

India
Canada
Australia

The report features the latest mid-2023 sales data from our dedicated DB6 database, including topline historical sales globally, by country and category, as well as individual brand performances, and long-term forecasts to 2027 and 2032.

Diving into the factors affecting the Dermatologicals market, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report sheds light on trends & developments across 8 in-depth country profiles with insights and predictions, as well as shorter profiles of other key markets .

Key questions investigated in this report:

What are the key differences from market to market in terms of growth trends, regulations and competitive landscape?
Which marketers and brands stand out and why?
How will NPD benefit Dermatologicals in the years ahead?
What are the opportunities for e-commerce in the global skincare market?
What new niches and demographics remain underserved?
How can marketers best respond to the growing demand for "clean" and sustainable products?

Data analysis within each country profile sees Antifungals sales divided into VYI, nail and general presentations .

The important adjacent category of hair & beauty supplements is also investigated.

Assessing the short-term outlook, the report also includes full year 2023 & 2024 forecasts for all categories in each market profiled.

With a high degree of launch activity among Dermatologicals, new product development is explored across markets. Brand case studies evaluate the key lessons to be learned from rising star brands and established products, including consumer messaging, digital strategies, line extensions, portfolio development and brand strategies.